Nabriva Therapeutics Balance Sheet Health
Financial Health criteria checks 0/6
Nabriva Therapeutics has a total shareholder equity of $-16.3M and total debt of $540.0K, which brings its debt-to-equity ratio to -3.3%. Its total assets and total liabilities are $10.6M and $26.9M respectively.
Key information
-3.3%
Debt to equity ratio
US$540.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.18m |
| Equity | -US$16.32m |
| Total liabilities | US$26.90m |
| Total assets | US$10.58m |
Recent financial health updates
Recent updates
Nabriva Therapeutics to effect 1-for-25 reverse stock split
Sep 15Nabriva stock soars 19% on distribution deal with Er-Kim for bacterial pneumonia drug Xenleta
Jul 18Need To Know: The Consensus Just Cut Its Nabriva Therapeutics plc (NASDAQ:NBRV) Estimates For 2022
Apr 04
Bullish: Analysts Just Made A Noticeable Upgrade To Their Nabriva Therapeutics plc (NASDAQ:NBRV) Forecasts
Aug 11We Think Some Shareholders May Hesitate To Increase Nabriva Therapeutics plc's (NASDAQ:NBRV) CEO Compensation
Jul 22Nabriva Therapeutics plc 2021 Q1 - Results - Earnings Call Presentation
May 08When Will Nabriva Therapeutics plc (NASDAQ:NBRV) Breakeven?
Feb 16Nabriva Therapeutics announces proposed public offering
Dec 10Nabriva Therapeutics shares gain as Sinovant expands Xenleta support in China
Dec 07Nabriva Therapeutics plc 2020 Q3 - Results - Earnings Call Presentation
Nov 08Financial Position Analysis
Short Term Liabilities: NBRV.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NBRV.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NBRV.F has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NBRV.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if NBRV.F has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NBRV.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.